Cargando…
Debating Pros and Cons of Total Neoadjuvant Therapy in Rectal Cancer
SIMPLE SUMMARY: Rectal cancers represent one third of all colorectal tumours. Patients diagnosed with localised colon cancer undergo surgery upfront, likely followed by adjuvant chemotherapy. Those diagnosed with localised rectal cancer, however, frequently benefit from neoadjuvant treatments with e...
Autores principales: | Sclafani, Francesco, Corrò, Claudia, Koessler, Thibaud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699289/ https://www.ncbi.nlm.nih.gov/pubmed/34944980 http://dx.doi.org/10.3390/cancers13246361 |
Ejemplares similares
-
Promises and Challenges of Predictive Blood Biomarkers for Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
por: Machado Carvalho, Joao Victor, et al.
Publicado: (2023) -
Emerging Trends for Radio-Immunotherapy in Rectal Cancer
por: Corrò, Claudia, et al.
Publicado: (2021) -
The Fluoride Debate: The Pros and Cons of Fluoridation
por: Aoun, Antoine, et al.
Publicado: (2018) -
Rectal retractor in prostate radiotherapy: pros and cons
por: Ghaffari, Hamed, et al.
Publicado: (2022) -
Restaging rectal cancer following neoadjuvant chemoradiotherapy
por: Cuicchi, Dajana, et al.
Publicado: (2023)